Argus Upgrades Silk Road Medical (SILK) to Buy, 'expanding its commercial footprint'
Tweet Send to a Friend
Argus analyst Steve Silver upgraded Silk Road Medical (NASDAQ: SILK) from Hold to Buy with a price target of $24.00.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
